ALL ABOUT DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
Extreme heat on July 4, 2026, prompted U.S. officials to issue health warnings urging precautions during Independence Day celebrations.
Extreme heat on July 4, 2026, prompted U.S. officials to issue health warnings urging precautions during Independence Day celebrations.
Extreme heat on July 4, 2026, prompted U.S. officials to issue health warnings urging precautions during Independence Day celebrations.
Extreme heat on July 4, 2026, prompted U.S. officials to issue health warnings urging precautions during Independence Day celebrations.
Extreme heat on July 4, 2026, prompted U.S. officials to issue health warnings urging precautions during Independence Day celebrations.
Extreme heat on July 4, 2026, prompted U.S. officials to issue health warnings urging precautions during Independence Day celebrations.
Read MoreThe FDA expanded its Salmonella outbreak warning linked to Rosabella moringa powder capsules to 119 cases across 36 states.
Read MoreThe FDA upgraded the recall of Utz’s Zapp’s and Dirty potato chips to Class I due to salmonella contamination in the seasoning.
Read More
Over 150 people in seven Michigan counties have been sickened by a Cyclospora parasite outbreak linked to contaminated food or water.
Read More
Health Secretary RFK Jr. replaced all CDC vaccine advisers amid leaked emails exposing political interference in vaccine policy decisions.
Read More
The FDA announced a nationwide recall of 11,460 bottles of chlorthalidone 25 mg blood pressure tablets due to dissolution test failures.
Read More
Pennsylvania reports 84 confirmed measles cases across six counties as of June 26, 2026, amid an ongoing outbreak since April.
Read More
The Democratic Republic of Congo reports 1,274 confirmed Ebola cases and 360 deaths in its 17th outbreak as of June 27, 2026.
Read More
The New England Journal of Medicine retracted a 2019 paper on Amgen’s Tavneos trial after FDA found data manipulation and proposed withdrawing approval.
Read More
The FDA approved Pfizer’s Ibrance as maintenance therapy for HR-positive, HER2-positive metastatic breast cancer in combination with trastuzumab and endocrine therapy.
Read More
